Dieter Weinand will become President of Bayer HealthCare Pharmaceuticals from 1 August. At the same time he will join the Executive Committee of Bayer HealthCare.
He will join Bayer from Otsuka Pharmaceutical Development & Commercialisation, located in Princeton, NJ, US, where he is currently President, Global Commercialisation for a US$13bn revenue healthcare business.
Weinand has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry. He has been responsible for different markets such as Asia-Pacific, Europe, Middle East, Africa, Latin America and the USA at companies including Pfizer and Bristol-Myers Squibb as well as for the marketing of products in different therapeutic areas such as cardiology, oncology, pulmonology, dermatology, immunology and inflammation.
